Our cutting edge biosensor technology provides you with advantages when developing new pharmaceuticals.
We offer you a contract research process enabled by our proven technology and a team of highly experienced application specialists. We select the best candidates to maximize your operations.
Our third generation biosensors technology is unique and patented and reduces animal testing and makes the drug development process more efficient and cost effective.
Attana will present at Stora Aktiedagen, an investor conference held in Gothenburg (Svenska Mässan) on November 12.
Attana is presenting new technologies for improved drug development at the Drug Discovery Innovation Programme, Frankfurt November 29-30, 2018. Welcome to listen or contact us for more information.